All tags miRNA Plasma miRNAs as potential early biomarkers for acute cardiac injury webinar

Plasma miRNAs as potential early biomarkers for acute cardiac injury webinar

Drug‑induced cardiac injury (DICI) detection remains a major safety issue in drug development 

Join Dr Stéphanie Glineur of Union Chimique Belge (UCB) as she review their recent acute DICI toxcity study comparing miR208a 3p and CTnT and CTnl, and discuss the future use of plasma miRNAs as early biomarkers for acute cardiac injury.

44:54
44:54
Wistia video thumbnail - Plasma miRNAs as potential early biomarkers for acute cardiac injury

Thanks for reporting a problem. We'll attach technical data about this session to help us figure out the issue. Which of these best describes the problem?

Any other details or context?

Cancel
message
Enter your email to view for free
By entering your email you get free updates about relevant events, access to our
library of webinars, resource videos and research tools. We respect your privacy
and you can unsubscribe at any time from marketing communications.
Error text
 
 

Webinar topics:

  • Acute DICI toxicity study
  • Identification of plasma miRs as potential biomarkers
  • Performance comparison between miR208a 3p and cTnT and cTnI
  • Conclusions and Future Directions

About the presenter:

Dr Stéphanie Glineur holds a DVM and a PhD degree in Veterinary Sciences from the University of Liege (Belgium) and completed a 2.5 year post-doctoral fellowship at the National Institutes of Health in Bethesda (MD, USA). During her professional career, Stéphanie developed a deep expertise in immuno-pathology, genetics and molecular biology.

Stéphanie has over 10 years research experience, including the last 2 years as responsible for microRNA safety biomarker implementation and as a key contributor to mechanistic and investigative toxicology in drug development. She is currently lecturer in Animal Genetics at the Université libre de Bruxelles.